Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Total Current Liabilities (2020 - 2025)

IceCure Medical (ICCM) has disclosed Total Current Liabilities for 5 consecutive years, with $5.5 million as the latest value for Q4 2024.

  • On a quarterly basis, Total Current Liabilities rose 42.44% to $5.5 million in Q4 2024 year-over-year; TTM through Dec 2024 was $5.5 million, a 42.44% increase, with the full-year FY2024 number at $5.5 million, up 42.44% from a year prior.
  • Total Current Liabilities was $5.5 million for Q4 2024 at IceCure Medical, up from $3.9 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $5.5 million in Q4 2024 to a low of $3.7 million in Q4 2020.
  • A 5-year average of $4.3 million and a median of $4.0 million in 2021 define the central range for Total Current Liabilities.
  • Peak YoY movement for Total Current Liabilities: fell 10.72% in 2023, then surged 42.44% in 2024.
  • IceCure Medical's Total Current Liabilities stood at $3.7 million in 2020, then rose by 8.24% to $4.0 million in 2021, then rose by 7.86% to $4.3 million in 2022, then decreased by 10.72% to $3.9 million in 2023, then soared by 42.44% to $5.5 million in 2024.
  • Per Business Quant, the three most recent readings for ICCM's Total Current Liabilities are $5.5 million (Q4 2024), $3.9 million (Q4 2023), and $4.3 million (Q4 2022).